See the DrugPatentWatch profile for soma
Carisoprodol, commonly known by the brand name Soma, is still prescribed in the United States, although its use has declined and some states have implemented restrictions [1].
Why is Soma Prescribing Declining?
The decline in Soma prescriptions is linked to concerns about its potential for abuse and dependence, as well as its association with overdose deaths, particularly when combined with opioids [2][3]. The Drug Enforcement Administration (DEA) has classified carisoprodol as a Schedule IV controlled substance, indicating a lower potential for abuse compared to Schedule III drugs, but still subject to regulations [4].
When Did Restrictions on Soma Begin?
In 2010, the U.S. Food and Drug Administration (FDA) requested that manufacturers voluntarily withdraw Soma from the market due to safety concerns. While the drug was not fully withdrawn, this action signaled increased scrutiny and led to more cautious prescribing practices [2]. Several states have also enacted laws to restrict carisoprodol's use. For example, as of 2024, it is no longer a covered drug under Medicare Part D in many plans, and some states have classified it as a Schedule IV drug or imposed limits on refills [1][4].
How Does Soma Work and What Is It Used For?
Soma is a muscle relaxant that works by blocking pain sensations between the nerves and the brain [1]. It is primarily prescribed to relieve discomfort associated with acute, painful musculoskeletal conditions [1]. However, due to the associated risks, it is typically intended for short-term use [2].
What Are the Risks Associated with Soma?
Soma carries risks including drowsiness, dizziness, and potential for dependence. Its use has been linked to increased risk of death, especially when combined with other central nervous system depressants like alcohol or opioids [2][3]. Withdrawal symptoms can occur if the medication is stopped abruptly after prolonged use [1].
Are There Alternatives to Soma?
Yes, numerous alternatives exist for managing musculoskeletal pain. These include other muscle relaxants with potentially different risk profiles, non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy, and other pain management strategies [1]. The choice of treatment depends on the specific condition, patient history, and physician's assessment of risks and benefits.